Thomson reuters report

Thomson Reuters press-release: World Generic Medicines Congress Europe

The World Generic Medicines Congress Europe organized by Health Network Communications brought together industry stakeholders, decision makers, and experts for two days of presentations and discussions focused on market challenges and portfolio strategy. The industry has seen a collapse of traditional commodity generic models, while a new model is emerging from innovation and consolidation, supported by strategic geographic expansion. The focus of generic companies to be the cheapest, most agile, and most integrated has become more difficult. The volume-driven growth has ended, and as opportunities evolve to include respiratory products, biosimilars, and niche products, they require new skills that necessitate looking outside the traditional generics space.

In this post- event report by Molly Bowman, Senior Manager – Newport Content & API Intelligence, Thomson Reuters, covered issues discussed at the conference, like:

  • Generic Commercial Strategy
  • Global Market Opportunities
  • Strategies For Biosimilars
  • Portfolio Planning
  • and many more!

Download Report

Leave a Reply

Your email address will not be published. Required fields are marked *